CURLF - Curaleaf Holdings, Inc.


0.954
-0.018   -1.918%

Share volume: 1,154,517
Last Updated: 04-25-2025
Pharmaceutical Products/Medicinal Chemicals: -0.06%

PREVIOUS CLOSE
CHG
CHG%

$0.97
-0.02
-0.02%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
19%
Profitability 0%
Dept financing 25%
Liquidity 0%
Performance 40%
Performance
5 Days
-1.88%
1 Month
4.84%
3 Months
-24.58%
6 Months
-41.83%
1 Year
-41.83%
2 Year
-41.83%
Key data
Stock price
$0.95
P/E Ratio 
N/A
DAY RANGE
$0.92 - $1.12
EPS 
N/A
52 WEEK RANGE
$0.68 - $1.74
52 WEEK CHANGE
-$41.83
MARKET CAP 
0.000
YIELD 
N/A
SHARES OUTSTANDING 
0.000
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
05-08-2025
BETA 
0.00
PUBLIC FLOAT 
N/A
AVERAGE 10 VOLUME 
$698,114
AVERAGE 30 VOLUME 
$601,364
Company detail
CEO: Matt Darin
Region: US
Website: curaleaf.com
Employees: 5,600
IPO year: 2018
Issue type:
Market: OTCM
Industry: Pharmaceutical Products/Medicinal Chemicals
Sector: Manufacturing

Curaleaf Holdings, Inc. operates as an integrated medical and wellness cannabis operator in the United States. It operates in two segments, Cannabis Operations and Non-Cannabis Operations. The Cannabis Operations segment engages in the production and sale of cannabis through retail and wholesale channels. The Non-Cannabis Operations segment provides professional services, including cultivation, processing, and retail know-how and back office administration, intellectual property licensing, real estate leasing services, and lending facilities to medical and adult-use cannabis licensees under management service agreements. It offers oil-based formulations, such as vaporizing, cartridges, tinctures, and capsules; and ground-flower. The company also provides hemp-based CBD products. As of March 9, 2021, it operated 101 dispensaries, 23 cultivation sites, and 30 processing sites in 23 states of the United States. The company was founded in 2010 and is headquartered in Wakefield, Massachusetts.

Recent news
loading